MedStar-Georgetown Surgical Outcomes Research Center, Washington, District of Columbia; Department of Surgery, MedStar-Georgetown University Hospital, Washington, District of Columbia.
MedStar-Georgetown Surgical Outcomes Research Center, Washington, District of Columbia; MedStar Health Research Institute, Hyattsville, Maryland.
J Surg Res. 2020 Mar;247:180-189. doi: 10.1016/j.jss.2019.07.102. Epub 2019 Nov 18.
Minimally invasive surgery (MIS) for colorectal cancer (CRC) is increasingly common; however, uptake has differed by hospital type. It is unknown how these trends have evolved for laparoscopic or robotic approaches in different types of hospitals. This study assesses temporal trends for MIS utilization and examines differences in surgical outcomes by hospital type.
The National Cancer Database was queried for patients who underwent CRC surgery between 2010 and 2015. Time-trend analysis of MIS utilization was performed for both approaches by hospital type (community, comprehensive community, integrated network, academic). Multivariate logistic regression models were used to examine MIS utilization, differences in case severity, and surgical outcomes by hospital type, after controlling for patient characteristics.
Across all hospital types, community hospitals had the lowest rate of laparoscopic (36.8%) and robotic (3.3%) procedures for CRC (P < 0.001). Community hospitals also exhibited a significant lag in adoption rate of robotic surgery (colon = 0.84% versus 1.41%/y; rectum = 2.14% versus 3.88 %/y). Community hospitals performing MIS had worse outcomes, including the most frequent conversions to open (colon = 15.2%; rectal = 17.1%) and highest 90-day mortality (colon = 6%; rectal = 3.2%) (P < 0.001). Finally, compared with laparoscopic colon surgery at academic centers, community centers treated lower grade tumors (OR 0.938, P < 0.05) with higher 30-day (OR 1.332, P < 0.05) and 90-day mortality (OR 1.210, P < 0.05).
MIS for CRC lags at the community level and experiences worse postoperative outcomes. Future initiatives must focus on understanding and correcting this trend to ensure uniform access to high-quality surgical care.
微创外科(MIS)治疗结直肠癌(CRC)的应用越来越普遍;然而,不同医院类型的采用率存在差异。目前尚不清楚在不同类型的医院中,腹腔镜或机器人方法的这些趋势是如何演变的。本研究评估了 MIS 应用的时间趋势,并检查了医院类型对手术结果的差异。
国家癌症数据库(National Cancer Database)查询了 2010 年至 2015 年间接受 CRC 手术的患者。按医院类型(社区、综合社区、综合网络、学术)对腹腔镜和机器人方法的 MIS 使用率进行时间趋势分析。在控制患者特征后,使用多变量逻辑回归模型检查医院类型对 MIS 使用率、病例严重程度差异和手术结果的影响。
在所有医院类型中,社区医院 CRC 腹腔镜(36.8%)和机器人(3.3%)手术的比例最低(P<0.001)。社区医院机器人手术的采用率也明显滞后(结肠=0.84%比 1.41%/年;直肠=2.14%比 3.88%/年)。进行 MIS 的社区医院手术结果较差,包括最频繁的转为开放手术(结肠=15.2%;直肠=17.1%)和最高的 90 天死亡率(结肠=6%;直肠=3.2%)(P<0.001)。最后,与学术中心的腹腔镜结肠手术相比,社区中心治疗的肿瘤分级较低(OR 0.938,P<0.05),30 天(OR 1.332,P<0.05)和 90 天死亡率(OR 1.210,P<0.05)较高。
CRC 的 MIS 在社区层面滞后,术后结果较差。未来的计划必须侧重于理解和纠正这一趋势,以确保获得高质量的手术护理。